About Danshen
Chinese red-sage root, a major traditional cardiovascular herb (tanshinones, salvianolic acids). Most clinical data comes from injectable/IV preparations or multi-herb TCM formulas studied in China, often low methodological quality and not applicable to Western oral extracts. Oral single-herb RCT evidence is weak. Notable interaction risk: may potentiate warfarin/anticoagulants. Grade low.
What Danshen supports
- Traditional cardiovascular herb; oral human evidence limited
How much Danshen to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
100–1000
mg
No established oral therapeutic dose in Western practice; most trials use injectable/IV preparations or TCM combination formulas. Nominal range for an oral blend component.
Clinical evidence
Limited clinical evidence. Mostly injectable/TCM-combination studies; weak oral single-herb RCT data.
Reference